HIV mutation literature information.


  HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy.
 PMID: 32556165       2020       The Journal of antimicrobial chemotherapy
Table: A146P


  Selection of HLA-B57-associated Gag A146P mutant by HLA-B*48:01-restricted Gag140-147-specific CTLs in chronically HIV-1-infected Japanese.
 PMID: 21473930       2011       Microbes and infection
Abstract: The sequence analysis of Gag146 in 261 chronically HIV-1-infected Japanese showed the accumulation of the A146P mutation in HLA-B*48:01(+) individuals.
Abstract: These findings together indicate that the A146P mutant is accumulating in Japanese by selection by GI8-specific CTLs.
Abstract: We herein demonstrated Gag140-147(GI8) to be the optimal epitope rather than LI10 and that GI8-specific T cells failed to recognize the A146P mutant virus-infected cells.


  Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein.
 PMID: 19109381       2009       Journal of virology
Abstract: To answer the question, the RRCs were quantified for escape mutations in three immunodominant HLA-B*57/B*5801 epitopes in capsid: A146P in IW9 (RRC(P146) = 0.91), A163G in KF11 (RRC(G163) = 0.89), and T242N in TW10 (RRC(N242) = 0.86).


  Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.
 PMID: 15067030       2004       The Journal of experimental medicine
Abstract: The A146P mutation prevented NH2-terminal trimming of the optimal epitope by the endoplasmic reticulum aminopeptidase I.



Browser Board

 Co-occurred Entities




   Filtrator